Unknown PHASE3 INTERVENTIONAL 2-arm NCT03266913

Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia

Sponsor: Hormozgan University of Medical Sciences

Interventions Probiotic

Updated 7 times since 2017 Last updated: Aug 29, 2017 Started: Aug 1, 2017 Primary completion: Oct 1, 2017 Completion: Nov 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Hyperbilirubinemia, Neonatal and is currently ongoing. Hormozgan University of Medical Sciences leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE3
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hormozgan University of Medical Sciences

Data source: Hormozgan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bandar Abbas, Iran